Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A murine model for B-lymphocyte somatic cell gene therapy

N Sutkowski1, M L Kuo, A Varela-Echavarria

  • 1Department of Molecular Genetics and Microbiology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854.

Proceedings of the National Academy of Sciences of the United States of America
|September 13, 1994
PubMed
Summary

Researchers developed a new method for gene transfer into B lymphocytes, crucial for treating metabolic and immune disorders. This efficient protocol bypasses drug selection, enabling gene therapy applications in mature B cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interim PET-CT-guided therapy in elderly patients with Hodgkin lymphoma-a retrospective national multi-center study.

Annals of hematology·2019
Same author

3,5-T2 and 3,3',5-T3 Regulate Cerebellar Thyroid Hormone Signalling and Myelin Molecular Dynamics in Tilapia.

Scientific reports·2019
Same author

A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.

Neurogastroenterology and motility·2017
Same author

A complete chitinolytic system in the atherinopsid pike silverside Chirostoma estor: gene expression and activities.

Journal of fish biology·2016
Same author

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis.

Alimentary pharmacology & therapeutics·2016
Same author

Effect of resveratrol and lipoic acid on sirtuin-regulated expression of metabolic genes in bovine liver and muscle slice cultures.

Journal of animal science·2015

Area of Science:

  • Immunology
  • Gene Therapy
  • Cell Biology

Background:

  • Mature primary B lymphocytes are potential targets for somatic cell gene therapy, offering advantages for metabolic and immunologic disorders.
  • B cells can act as antigen-presenting cells for immune responses or be manipulated for autoimmune disease treatment.
  • Efficient gene transfer into mature B cells is challenging due to limitations of current protocols requiring extensive cell culture and drug selection.

Purpose of the Study:

  • To develop an efficient and rapid protocol for introducing exogenous genes into mature primary B cells.
  • To overcome the limitations of existing gene transfer methods that preclude the use of mature B cells.
  • To establish a method for gene transfer into B cells without the need for in vitro expansion or drug selection.

Main Methods:

Related Experiment Videos

  • Utilized retroviral vectors carrying the human adenosine deaminase (hADA) gene as a marker.
  • Developed a protocol for direct gene transfer into primary B cells, avoiding drug selection.
  • Adoptively transferred gene-modified B cells into severe combined immunodeficient (SCID) mice.

Main Results:

  • Demonstrated an efficient and rapid protocol for gene introduction into primary B cells.
  • Successfully achieved continuous expression of the human adenosine deaminase gene in transferred B cells.
  • Detected gene-modified B cells expressing hADA in recipient mouse spleens for at least 3 months post-transfer.

Conclusions:

  • The developed protocol enables efficient gene transfer into mature primary B cells without drug selection.
  • This method holds promise for applications in gene therapy, particularly for metabolic and immunologic disorders.
  • Long-term expression of therapeutic genes in B lymphocytes can be achieved, supporting their use in treating various diseases.